바이오메디컬소프트웨어학과

(김 필 교수의 전문성 관련 기사)
-먹으면 살 빠지는 대체육 나올까 (https://health.chosun.com/site/data/html_dir/2024/06/20/2024062002211.html)
-미생물이 만든 대체단백질, 우주식량으로도 쓰인다 (https://www.dongascience.com/news.php?idx=66206)
-2024 대한민국 과학축제 전시 (https://blog.naver.com/cabiotech/223461357900)
-식물성 대체육은 진화 중 (https://m.health.chosun.com/svc/news_view.html?contid=2022081902155)
-옛날 '콩고기'는 잊어라 (https://m.health.chosun.com/svc/news_view.html?contid=2022090601883)
-그린바이오산업 소개 대중강연 및 인터뷰 (https://youtu.be/HcGqMOFbVGg?si=okJ61E98FdplyIjS; https://youtu.be/S765usMmo6w?si=ogQaq9bbQuRN)
-대체단백질식품신소재 원천기술연구단 소식 (https://blog.naver.com/cabiotech)

Professor Pil KIM graduated his bachelor’s degree at Korea University (Food Technology), master and Ph. D. degrees at KAIST (Biological Sciences). He has conducted postdoc fellows at KRIBB (Fermentation Systems RU) and at Michigan State University (Dept. of Biochemistry and Molecular Biology) as well as at the Tongyang Confectionery Co. as a special military service before the assignment as a full-time professor at the Catholic Univ. of Korea (Dept. of Biotechnology) since 2004. He has been studying on developments of biologics/biotics based on metabolic engineering and cellular evolutionary engineering of single-cells and proteins, on microbial energy metabolism and its physiology. He has accomplished Technology Fee Incomes and has founded a company during his adjunct professorshi. He is a current director of a research group composing 10 domestic institutes entitled “Development of Novel Food Ingredients for Alternative Proteins” funded by Korean Ministry of Science, Technology, and ICT. 

야마오카 야스요 교수는 동경약학대학교(학사), 동경대학교(석사), 사이타마대학교(박사)에서 학위를 받았으며, 포항공과대학교에서 박사후연구원 및 연구교수, 이후 서울대학교 연구교수를 거쳐, 2021년 3월에 가톨릭대학교 생명공학과 조교수로 임용되었다. 세포생물학과 분자생문학을 기반으로 식물 지질 대사와 기능 해석, 스트레스 내성 메커니즘 해석을 통해 식물의 활용 방안을 높이는 연구를 수행 중이다. 이를 위해 모델 식물인 애기 장대, 모델 미세조류인 클라미도모나스를 기반으로 기초연구를 수행하며, 이를 개구리밥 및 클로렐라에 적용하여 실용화를 검토하고 있다. 한국식물학회(KSPB), 한국미생물 생명공학회(KMB), 국제생물지질학회(SPL), 미국식물생리학회 (ASPB), 일본식물생리학회(JSPP), 일본식물지절학연구회(JAPLR)에서 정회원, 아시아-태평양 식물 지질학회(ASPL) 위원으로 활동 중이다.

Professor Yasuyo Yamaoka is an assistant professor in the Department of Biotechnology at the Catholic University of Korea. She earned her bachelor's degree from Tokyo University of Pharmacy and Life Sciences (Tokyo, Japan), followed by a master's degree from The University of Tokyo (Tokyo, Japan). Later, she completed her doctoral studies at Saitama University (Saitama, Japan) after a change in her supervising professor's position. Subsequently, she worked as a postdoctoral researcher and research professor at Pohang University of Science and Technology (Pohang, Korea), then served as a research professor at Seoul National University (Seoul, Korea) before joining the Catholic University of Korea as an assistant professor in 2021. Professor Yamaoka's research focuses on understanding plant lipid metabolism and function using cellular and molecular biology techniques. She aims to expand the applications of plant biotechnology for various uses. Her lab collaborates internationally with countries such as Japan, the United States, and France, and provides student education to participate in global research activities. Currently, she is an active member of several professional societies, including the Korean Society of Plant Biologists (KSPB), Korean Society for Microbiology and Biotechnology (KMB), International Symposium on Plant Lipids (ISPL), American Society of Plant Biologists 

정정민 교수는 University of Auckland (New Zealand)와 강원대학교에서 학사, 석/박사 학위를 받았으며, University of Michigan (USA)에서  박사후연구원으로 재직 후,  2021년 3월부터 가톨릭대학교 생명공학과에서 조교수로 재직 중에 있다. Cryo-electron microscopy (Cryo-EM) 및 Cryo-electron tomography (Cryo-ET)를 비롯한 첨단 바이오이미징 기술을 활용하여 생명체 내 주요 고분자의 구조와 기능에 대한 연구를 수행 중이다. 특히 다제내성 감염성 질환에 대한 새로운 치료제 및 백신 개발에 필요한 기초 연구를 진행 중이며, 바이오이미징 전산처리에 접목 가능한 딥러닝 알고리즘 플랫폼 개발 또한 추진 중에 있다. Biophysical Society (USA), Microscopy Society of America (USA), 한국구조생물학회(KSSB), 한국현미경학회(KSM), 한국생명공학회(KSBB), 한국생화학분자생물학회(KSBMB), 한국분자세포생물학회(KSMCB)의 정회원이며, 한국 Cryo-EM 사용자 협회(KOCUA)의 운영위원, 한국단백질과학회(KSPS)의 집행위원, 그리고 한국미생물생명공학회(KMB)의 이사회 위원으로 활동하며 한국 및 글로벌 생명공학 발전에 중요한 역할을 하고 있다.

Professor Jeong Min Chung received his bachelor's and master's/Ph.D. degrees from the University of Auckland (New Zealand) and Kangwon National University. After serving as a postdoctoral researcher at the University of Michigan (USA), he has been an assistant professor in the Department of Biotechnology at the Catholic University of Korea since March 2021. He is conducting research on the structure and function of major macromolecules within living organisms using advanced bioimaging technologies, including Cryo-electron microscopy (Cryo-EM) and Cryo-electron tomography (Cryo-ET). In particular, he is working on foundational research necessary for the development of new therapeutics and vaccines for multi-drug resistant infectious diseases and is also developing a deep learning algorithm platform that can be integrated with bioimaging computational processing. 

박용일 교수는 1996년 미국 플로리다대학교(University of Florida)의 Microbiology and Cell Science학과에서 박사학위(Ph.D.), 1997년부터 Johns Hopkins University에서 박사후연구원(Post-doc) 및 선임연구원(Associate Research Scientist)으로 근무하였음. 1999년부터 한국생명공학연구원(KRIBB) 객원선임연구원으로 근무, 2002년부터 가톨릭대학교 생명공학과에서 조교수, 부교수, 정교수로 근무하면서 학과장, LINC 사업단 부단장, 경기도 GRRC 센터 (생체의약선도분자연구센터) 센터장 등으로 활동하였음. 2020년부터 의생명과학과에서 학과장 등으로 근무하였고, 현재 가톨릭대학교 성심 연구처장과 성심 산학협력단장, BK21-FOUR 사업단장을 역임하고 있음. 주요 연구 관심사는 주로 비만, 당뇨, 암, 골다공증 등 대사성질환에 대한 천연물 기반 신규 치료제 및 건강기능성 소재 개발 분야로서, SCIE 국제학술지 110여편, KCI 국내학술지 40여편, 70여건의 특허를 출원 또는 등록하였고, 체코 프라하 소재 대학과 슬로바키아 과학기술원 연구진과 국제공동연구를 활발히 수행하고 있으며, 한국당과학회 회장, 아시아 당과학회 운영위원, 한국균학회 부회장등을 역임하고 이사 및 감사로 활동하였으며, 한국신약개발연구조합의 자문교수로 활동 중임.

Prof. Park earned his Ph.D. in 1996 from the Dept. of Microbiology and Cell Science at the University of Florida. He continued his research experience as a Post-doc and Associate Research Scientist at the Johns Hopkins University during 1997~1999 and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) as a visiting senior researcher during 1999~2001. He started his professorship at the Dept. of Biotechnology, The Catholic University of Korea from 2002. Since 2020, he has been a full professor of the Dept. of Medical and Biological Sciences and currently serves as the President of CUK Songsim Industry-Academic Cooperation Foundation and Songsim Office of Research Affairs. His research has focused mainly on the development of natural compound-based therapeutics and health beneficial functional biomaterials for metabolic diseases such as obesity, diabetes, and cancer, with the publication of approximately 110 SCI and 42 KCI peer-reviewed research papers and over 70 patents pending and/or registered. His research group has actively collaborated for over 15 years with foreign research groups in Czech Republic, Slovakia, etc. He served as the President of the Korean Society for Glycoscience and Glycotechnology and Vice President of The Korean Society of Mycology, and currently serves as an advisory board member for the Korea Drug Research Association.

남재환 교수는 고려대학교 생물학과에서 학사, 석사, 박사 과정을 졸업하였고 미국 NIH에서 교환연구원 및 Visiting Fellow로 근무하였음. 이후 국립보건연구원 (現 질병관리청) 에서 보건연구관으로 근무하였으며 2005년부터 현재까지 가톨릭대학교 교수로써 근무하고 있음. 1997년부터 현재까지 미국바이러스학회 정회원이며 2011년부터 현재까지 International Journal of Obesity의 Editorial Board로 활동하고 있으며 2024년 현재 대한바이러스학회 차기회장직을 겸하고 있음. 주요 관심사로는 RNA를 면역증강제로 활용한 바이러스 백신 개발을 진행하고 있음. 또한 현재 차세대 백신 플랫폼으로써 떠오르고 있는 mRNA vaccine과 관련된 다양한 연구를 진행하고 있으며 다양한 바이러스 백신 및 암 백신 개발, mRNA 전달용 지질 전달체 개발, mRNA 백신의 면역 효과와 부작용 기전 연구 등을 수행하고 있음. 여러 편의 mRNA 관련 논문을 출판하였으며 특히 국내에서는 최초로 mRNA를 활용한 면역 항암 치료제 연구 성과를 논문으로 출판하였음. 이상의 활동을 통해 국내에서 mRNA 분야의 연구 인프라 구축과 투자 확대에 기여하고 있음.

Professor Nam Jaehwan is a faculty member in the Department of Biomedical Science at the Catholic University of Korea. He earned his bachelor's, master's, and doctoral degrees from Korea University's Department of Biology and worked at the US National Institutes of Health (NIH) as an exchange researcher and visiting fellow. Subsequently, he served as a health researcher at the National Institute of Health (now the Korea Disease Control and Prevention Agency) before joining the Catholic University of Korea as a professor in 2005. Since 1997, he has been a regular member of the American Society for Virology and has served on the Editorial Board of the International Journal of Obesity since 2011. As of 2024, he also holds the position of the next president of the Korean Society for Virology. His primary research focuses on developing virus vaccines using RNA as an immune enhancer. He is also actively involved in various studies related to mRNA vaccines, including their immune effects, side effects, and delivery mechanisms. Professor Nam has published numerous papers on mRNA-related topics and notably pioneered research on immune anti-cancer therapy using mRNA in Korea. Through his work, he contributes to expanding research infrastructure and investment in the mRNA field domestically.